Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  NuPathe Inc    PATH

No quotes available
-- USD   0.00%
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement ..
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
08/09Earnings Release
More about the company
Latest news on NUPATHE INC
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2013 NUPATHE INC : Program Participations and Positive Stock Movements - Research Rep..
2013 NUPATHE INC : NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investi..
2013 NUPATHE INC : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of NU..
2013 NUPATHE INC : Harwood Feffer LLP Announces Investigation of NuPathe, Inc.
2013 NUPATHE INC : PATH SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter is Investi..
2013 NUPATHE INC : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces In..
More news
Sector news : Pharmaceuticals - NEC
04:52pDJASTRAZENECA : 2Q 2016 -- Forecast
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
More sector news : Pharmaceuticals - NEC
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Richard S. Egosi President, Chief Executive Officer & Director
Deborah A. Griffin Chief Financial Officer, Treasurer, Director & VP
Mark W. Pierce Chief Scientific Officer & Vice President
Austin D. Kim Secretary
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NUPATHE INC0.00%0
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results